Profile and acute mortality outcome of patients admitted with cryptococcal meningitis to an urban district hospital in KwaZulu-Natal, South Africa

References

• Jarvis JN, Boulle A, Loyse A, et al. High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out. AIDS. 2009;23(9):1182.10.1097/QAD.0b013e32832be0fc
   PubMed Web of Science ®Google Scholar
• Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23(4):525–30.10.1097/QAD.0b013e328322ffac
   PubMed Web of Science ®Google Scholar
• Harrison TS. The burden of HIV-associated cryptococcal disease. AIDS. 2009;23(4):531–2.10.1097/QAD.0b013e328322ffc3
   PubMed Web of Science ®Google Scholar
• CDC. Fighting a deadly fungus: A new strategy to reduce deaths due to Cryptococcus. 2011 [cited 2013 Sep 11]. Available from: http://www.cdc.gov/ncezid/dfwed/PDFs/FACTSHEET_Cryptococcus_remediated.pdf
   Google Scholar
• CDC. Cryptococcal meningitis: a deadly fungal disease among people living with HIV/AIDS. Centers for Disease Control and Prevention (CDC). 2012 [cited 2013 Sep 11]. Available from: www.cdc.gov/fungal/pdf/at-a-glance-508c.pdf
   Google Scholar
• Lawn SD, Harries AD, Anglaret X, et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897–908.10.1097/QAD.0b013e32830007cd
   PubMed Web of Science ®Google Scholar
• Jarvis JN, Meintjes G, Williams A, et al. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis. 2010;10:67.10.1186/1471-2334-10-67
   PubMed Web of Science ®Google Scholar
• NDOH. Ch 14 – neurological disorders. Standard treatment guidelines and essential drug list. Pretoria: National Department of Health (NDOH); 2006. p. 206–9.
   Google Scholar
• McCarthy K, Meintjes G, Arthington-Skaggs B, et al. Guidelines for the prevention, diagnosis and management of cryptococcal meningitis and disseminated cryptococcosis in HIV-infected patients. South Afr J HIV Med. 2008;8(3):25.
   Google Scholar
• Sloan, D, Dlamini, S, Paul, N, et al.. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Cochrane Database Syst Rev. 2008(4):CD005647.
   Google Scholar
• Lessells RJ, Mutevedzi PC, Heller T, et al. Poor long-term outcomes for cryptococcal meningitis in rural South Africa. South Afr Med J [Suid-Afrikaanse tydskrif vir geneeskunde]. 2011 Apr;101(4):251–2.
   PubMed Web of Science ®Google Scholar
• Moosa MY, Coovadia YM. Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997 Feb;24(2):131–4.10.1093/clinids/24.2.131
   PubMed Web of Science ®Google Scholar
• Lightowler JV, Cooke GS, Mutevedzi P, et al. Treatment of cryptococcal meningitis in KwaZulu-Natal, South Africa. PloS One. 2010;5(1):e8630.10.1371/journal.pone.0008630
   Google Scholar
• Sirkar, S. Quality improvement process/cycle: action orientated audit. 2006 [cited 2012 Dec 17]. Available from: http://www.kznhealth.gov.za/family/pres6.pdf
   Google Scholar
• Mwaba P, Mwansa J, Chintu C, et al. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J. 2001 Dec;77(914):769–73.10.1136/pmj.77.914.769
   PubMed Web of Science ®Google Scholar
• Bicanic T, Meintjes G, Wood R, et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America 2007 Jul 1;45(1):76–80.10.1086/518607
   PubMed Web of Science ®Google Scholar
• Jarvis JN, Meintjes G, Williams Z, et al. Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis. South Afr Med J. [Suid-Afrikaanse tydskrif vir geneeskunde]. 2010 Jun;100(6):378–82.
   PubMed Web of Science ®Google Scholar
• UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. Geneva: Joint United Nations Programme on HIV/AIDS [UNAIDS]; 2013 [cited 2013 Nov 29]. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf
   Google Scholar
• WHO. Gender inequalities and HIV. 2013 [cited 2013 Nov 15]. Available from: http://www.who.int/gender/hiv_aids/en/
   Google Scholar
• Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8(7):e1001056.10.1371/journal.pmed.1001056
   PubMed Web of Science ®Google Scholar
• Giordano TP, Gifford AL, White AC Jr, et al. Retention in care: a challenge to survival with HIV infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2007;44(11):1493–9.10.1086/516778
   PubMed Web of Science ®Google Scholar
• Bicanic T, Harrison TS. Cryptococcal meningitis. Brit Med Bulletin. 2004;72:99–118.
   PubMed Web of Science ®Google Scholar
• KZN Health. Clinical protocols 2005: cryptococcal meningitis. 2005 [cited 2011 Oct 19]. Available from: www.kznhealth.gov.za/medicine/crypto.pdf
   Google Scholar
• Jarvis JN, Meintjes G, Harrison TS. Outcomes of cryptococcal meningitis in antiretroviral naive and experienced patients in South Africa. J Infect. 2010 Jun;60(6):496–8.10.1016/j.jinf.2010.03.007
   PubMed Web of Science ®Google Scholar
• Jarvis JN, Lawn SD, Wood R, et al. Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action. Clin Infect Dis. 2010;51(12):1463–5.10.1086/652986
   PubMed Web of Science ®Google Scholar
• Klausner JD, Govender N, Oladoyinbo S, et al. Preventing AIDS deaths: cryptococcal antigen screening and treatment. Lancet Infect Dis. 2012;12(6):431–2.10.1016/S1473-3099(12)70094-4
   PubMed Web of Science ®Google Scholar
• Jarvis JN, Harrison TS, Lawn SD, et al. Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa. PloS One. 2013;8(7):e69288.10.1371/journal.pone.0069288
   PubMed Web of Science ®Google Scholar
• Govender NP. Phased implementation of screening for cryptococcal disease in South Africa. SAMJ. South Afr Med J. 2012;102:914–7.
   PubMed Web of Science ®Google Scholar
• Govender N, Meintjes G, Bicanic T, et al. Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update. S Afr J HIV Med. 2013;14(2):76–86.
   Web of Science ®Google Scholar